Karolinska Institutet
Browse

Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5.

Download (424.8 kB)
journal contribution
posted on 2024-10-25, 13:33 authored by Edyta Golembiewska, Abdul Rashid QureshiAbdul Rashid Qureshi, Lu Dai, Bengt LindholmBengt Lindholm, Olof Heimbürger, Magnus Söderberg, Torkel BrismarTorkel Brismar, Jonaz RipswedenJonaz Ripsweden, Peter BaranyPeter Barany, Richard J Johnson, Peter StenvinkelPeter Stenvinkel

BACKGROUND: Vascular calcification (VC) is an independent predictor of cardiovascular disease (CVD) present in 30-70% of patients with chronic kidney disease (CKD). Copeptin is a sensitive surrogate marker of arginine vasopressin (AVP), which is involved in many pathophysiologic processes in CKD. The aim of the present study was to explore the association of copeptin with VC in CKD stage 5. 

METHODS: Copeptin was investigated in conjunction with living donor kidney transplantation in 149 clinically stable CKD stage 5 patients (CKD5), including 53 non-dialyzed (CKD5-ND) and 96 dialysis patients treated by peritoneal dialysis (PD) (n = 43) or hemodialysis (HD) (n = 53). We analyzed the association of copeptin with presence and extent of VC ascertained both histologically in biopsies from the inferior epigastric artery (n = 137) and by coronary artery calcification (CAC) score measured by computed tomography. 

RESULTS: Patients with higher copeptin were older, had higher systolic blood pressure, higher prevalence of CVD and their preceding time on chronic dialysis was longer. In Spearman's rank correlations (Rho), copeptin concentrations were significantly associated with CAC score (Rho = 0.27; p = 0.003) and presence of medial VC (Rho = 0.21; p = 0.016). Multivariate logistic regression analysis showed that 1-SD higher age, male gender, diabetes and 1-SD higher copeptin were significantly associated with the presence of moderate-extensive VC. 

CONCLUSIONS: High circulating levels of copeptin in CKD5 patients are independently associated with the degree of medial calcification ascertained by histology of arterial biopsies. Thus, plasma copeptin may serve as a marker of the uremic calcification process.

History

File version

  • Published

Publication status

Published online

Sub type

Article

Journal

BMC Nephrol

ISSN

1471-2369

eISSN

1471-2369

Volume

21

Issue

1

Pagination

43-

Article number

ARTN 43

Language

  • eng

Original self archiving date

2021-03-05

Usage metrics

    Articles

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC